EX
Extendicare Inc.
EXETF · OTC
$22.20 -0.05% (-$0.01)
1M -5.53%
Market Cap $2.91B
P/E Ratio 23.99x
Div. Yield 1.67%
ROE 36.34%
Bulios Fair Price
$16.65
25.0% downside
Current Price
$22.2
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EXETF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
38 /100
Fair P/B 7.19x
P/S 1.47x
P/E 23.99x
Growth
77 /100
Growing Book val. growth 54.73%
Rev. growth 10.74%
FCF growth N/A
Profitability
39 /100
Moderate FCF margin 2.73%
Op. margin 8.84%
Gross margin 31.56%
Quality
81 /100
Excellent Asset turnover 1.27x
ROA 7.80%
ROIC 11.41%
Debt
42 /100
Moderate Net debt/EBITDA 2.50x
Int. coverage 5.43x
Debt/Equity 1.60x
Stability
62 /100
Moderate Profitable years 6
EPS volatility 457.22%
Beta 1.16x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EXETF
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Michael R. Guerriere
Employees
23,500
Headquarters
Markham
Upcoming events
11 NOV
Earnings
Upcoming earnings report